- Home
- UROY vs OSUR Comparison
UROY vs OSUR Comparison
Compare UROY & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UROY
- OSUR
- Stock Information
- Founded
- UROY 2017
- OSUR 2000
- Country
- UROY Canada
- OSUR United States
- Employees
- UROY N/A
- OSUR N/A
- Industry
- UROY
- OSUR Medical/Dental Instruments
- Sector
- UROY
- OSUR Health Care
- Exchange
- UROY Nasdaq
- OSUR Nasdaq
- Market Cap
- UROY 294.0M
- OSUR 289.4M
- IPO Year
- UROY N/A
- OSUR 1986
- Fundamental
- Price
- UROY $2.13
- OSUR $3.64
- Analyst Decision
- UROY Strong Buy
- OSUR Hold
- Analyst Count
- UROY 2
- OSUR 2
- Target Price
- UROY $5.60
- OSUR $5.50
- AVG Volume (30 Days)
- UROY 2.4M
- OSUR 1.0M
- Earning Date
- UROY 12-12-2024
- OSUR 11-06-2024
- Dividend Yield
- UROY N/A
- OSUR N/A
- EPS Growth
- UROY 256.61
- OSUR N/A
- EPS
- UROY 0.03
- OSUR 0.15
- Revenue
- UROY $27,478,292.00
- OSUR $224,263,000.00
- Revenue This Year
- UROY N/A
- OSUR N/A
- Revenue Next Year
- UROY $72.53
- OSUR N/A
- P/E Ratio
- UROY $82.15
- OSUR $24.10
- Revenue Growth
- UROY 31.26
- OSUR N/A
- 52 Week Low
- UROY $1.86
- OSUR $3.61
- 52 Week High
- UROY $3.76
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- UROY 31.97
- OSUR 39.55
- Support Level
- UROY $2.42
- OSUR $3.76
- Resistance Level
- UROY $2.70
- OSUR $4.14
- Average True Range (ATR)
- UROY 0.14
- OSUR 0.17
- MACD
- UROY -0.03
- OSUR -0.01
- Stochastic Oscillator
- UROY 10.94
- OSUR 1.02
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.